{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:15:17Z","timestamp":1791728117714,"version":"4.3.4"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00198-025-07553-7","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:55:54Z","timestamp":1748861754000},"page":"1129-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches"],"prefix":"10.1007","volume":"36","author":[{"given":"Mohammad Hasan","family":"Sharafi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Souri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Bakhshesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"7553_CR1","doi-asserted-by":"crossref","unstructured":"(2001) Osteoporosis prevention, diagnosis, and therapy. Jama 285:785\u2013795","DOI":"10.1001\/jama.285.6.785"},{"key":"7553_CR2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. The Lancet 377:1276\u20131287","journal-title":"The Lancet"},{"key":"7553_CR3","doi-asserted-by":"publisher","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","volume":"12","author":"AN Nowbar","year":"2019","unstructured":"Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R (2019) Mortality from ischemic heart disease: analysis of data from the World Health Organization and coronary artery disease risk factors From NCD Risk Factor Collaboration. Circ Cardiovas Qual Outcomes 12. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005375","journal-title":"Circ Cardiovas Qual Outcomes"},{"key":"7553_CR4","first-page":"2529","volume-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. American College of Cardiology Foundation Washington, DC, pp 2529\u20132532"},{"key":"7553_CR5","first-page":"19","volume":"5","author":"GN Farhat","year":"2008","unstructured":"Farhat GN, Cauley JA (2008) The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab 5:19","journal-title":"Clin Cases Miner Bone Metab"},{"key":"7553_CR6","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s11033-022-08088-4","volume":"50","author":"TA Azeez","year":"2023","unstructured":"Azeez TA (2023) Osteoporosis and cardiovascular disease: a review. Mol Biol Rep 50:1753\u20131763","journal-title":"Mol Biol Rep"},{"key":"7553_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S8756-3282(00)00381-1","volume":"27","author":"J Kanis","year":"2000","unstructured":"Kanis J, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585\u2013590","journal-title":"Bone"},{"key":"7553_CR8","first-page":"117","volume":"11","author":"D Sprini","year":"2014","unstructured":"Sprini D, Rini GB, Di Stefano L, Cianferotti L, Napoli N (2014) Correlation between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab 11:117","journal-title":"Clin Cases Miner Bone Metab"},{"key":"7553_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00198-018-4524-7","volume":"29","author":"N Ahmadi","year":"2018","unstructured":"Ahmadi N, Mao S, Hajsadeghi F, Arnold B, Kiramijyan S, Gao Y, Flores F, Azen S, Budoff M (2018) The relation of low levels of bone mineral density with coronary artery calcium and mortality. Osteoporos Int 29:1609\u20131616","journal-title":"Osteoporos Int"},{"key":"7553_CR10","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1152\/ajpendo.00552.2003","volume":"286","author":"R Vattikuti","year":"2004","unstructured":"Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686\u2013E696. https:\/\/doi.org\/10.1152\/ajpendo.00552.2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7553_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1573406411666150928111446","volume":"12","author":"A Kalampogias","year":"2016","unstructured":"Kalampogias A, Siasos G, Oikonomou E, Tsalamandris S, Mourouzis K, Tsigkou V, Vavuranakis M, Zografos T, Deftereos S, Stefanadis C (2016) Basic mechanisms in atherosclerosis: the role of calcium. Med Chem 12:103\u2013113","journal-title":"Med Chem"},{"key":"7553_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/biology13020111","volume":"13","author":"R Villa-Bellosta","year":"2024","unstructured":"Villa-Bellosta R (2024) Vascular calcification: a passive process that requires active inhibition. Biology 13:111. https:\/\/doi.org\/10.3390\/biology13020111","journal-title":"Biology"},{"key":"7553_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11596-019-1996-4","volume":"39","author":"B Nie","year":"2019","unstructured":"Nie B, Zhang S-y, Guan S-m, Zhou S-q, Fang X (2019) Role of Wnt\/\u03b2-catenin pathway in the arterial medial calcification and its effect on the OPG\/RANKL system. Curr Med Sci 39:28\u201336","journal-title":"Curr Med Sci"},{"key":"7553_CR14","doi-asserted-by":"publisher","first-page":"708470","DOI":"10.3389\/fcvm.2021.708470","volume":"8","author":"K Bundy","year":"2021","unstructured":"Bundy K, Boone J, Simpson CL (2021) Wnt signaling in vascular calcification. Front Cardiovasc Med 8. https:\/\/doi.org\/10.3389\/fcvm.2021.708470","journal-title":"Front Cardiovasc Med"},{"key":"7553_CR15","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/cells9122658","volume":"9","author":"S Reinhold","year":"2020","unstructured":"Reinhold S, Blankesteijn WM, Foulquier S (2020) The interplay of WNT and PPAR\u03b3 signaling in vascular calcification. Cells 9:2658","journal-title":"Cells"},{"key":"7553_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejphar.2015.05.023","volume":"763","author":"WM Blankesteijn","year":"2015","unstructured":"Blankesteijn WM, Hermans KC (2015) Wnt signaling in atherosclerosis. Eur J Pharmacol 763:122\u2013130","journal-title":"Eur J Pharmacol"},{"key":"7553_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat R, Manzoor M, Hussain A (2022) Wnt signaling pathway: a comprehensive review. Cell Biol Int 46:863\u2013877","journal-title":"Cell Biol Int"},{"key":"7553_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.33696\/Signaling.2.035","volume":"2","author":"N Weerackoon","year":"2021","unstructured":"Weerackoon N, Gunawardhana KL, Mani A (2021) Wnt signaling cascades and their role in coronary artery health and disease. J Cell Signal 2:52\u201362. https:\/\/doi.org\/10.33696\/Signaling.2.035","journal-title":"J Cell Signal"},{"key":"7553_CR19","doi-asserted-by":"publisher","first-page":"e007356","DOI":"10.1161\/JAHA.117.007356","volume":"7","author":"I Albanese","year":"2018","unstructured":"Albanese I, Khan K, Barratt B, Al-Kindi H, Schwertani A (2018) Atherosclerotic calcification: Wnt is the hint. J Am Heart Assoc 7:e007356. https:\/\/doi.org\/10.1161\/JAHA.117.007356","journal-title":"J Am Heart Assoc"},{"key":"7553_CR20","doi-asserted-by":"publisher","first-page":"e0188264","DOI":"10.1371\/journal.pone.0188264","volume":"12","author":"A Sebastian","year":"2017","unstructured":"Sebastian A, Hum NR, Murugesh DK, Hatsell S, Economides AN, Loots GG (2017) Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts. PLoS ONE 12:e0188264","journal-title":"PLoS ONE"},{"key":"7553_CR21","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.3390\/ijms20184653","volume":"20","author":"B Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs B, Vajda E, Nagy EE (2019) Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis. Int J Mol Sci 20:4653","journal-title":"Int J Mol Sci"},{"key":"7553_CR22","unstructured":"Morse AR (2017) The role of Wnt\/\u03b2-catenin antagonists-sclerostin and DKK1-in bone homeostasis and mechanotransduction."},{"key":"7553_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11033-020-06086-y","volume":"48","author":"A Singh","year":"2021","unstructured":"Singh A, Tandon S, Tandon C (2021) An update on vascular calcification and potential therapeutics. Mol Biol Rep 48:887\u2013896","journal-title":"Mol Biol Rep"},{"key":"7553_CR24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1017\/S1431927617012533","volume":"23","author":"I Perrotta","year":"2017","unstructured":"Perrotta I, Perri E (2017) Ultrastructural, elemental and mineralogical analysis of vascular calcification in atherosclerosis. Microsc Microanal 23:1030\u20131039","journal-title":"Microsc Microanal"},{"key":"7553_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/crat.201200443","volume":"48","author":"S Danilchenko","year":"2013","unstructured":"Danilchenko S, Kuznetsov V, Stanislavov A, Kalinkevich A, Starikov V, Moskalenko R, Kalinichenko T, Kochenko A, L\u00fc J, Shang J (2013) The mineral component of human cardiovascular deposits: morphological, structural and crystal-chemical characterization. Cryst Res Technol 48:153\u2013162","journal-title":"Cryst Res Technol"},{"key":"7553_CR26","first-page":"1","volume":"6","author":"RO Kareem","year":"2024","unstructured":"Kareem RO, Bulut N, Kaygili O (2024) Hydroxyapatite biomaterials: a comprehensive review of their properties, structures, medical applications, and fabrication methods. J Chem Rev 6:1\u201326","journal-title":"J Chem Rev"},{"key":"7553_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.yexcr.2014.01.011","volume":"323","author":"Y Lei","year":"2014","unstructured":"Lei Y, Sinha A, Nosoudi N, Grover A, Vyavahare N (2014) Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Exp Cell Res 323:198\u2013208","journal-title":"Exp Cell Res"},{"key":"7553_CR28","doi-asserted-by":"publisher","first-page":"639740","DOI":"10.3389\/fcvm.2021.639740","volume":"8","author":"W Jiang","year":"2021","unstructured":"Jiang W, Zhang Z, Li Y, Chen C, Yang H, Lin Q, Hu M, Qin X (2021) The cell origin and role of osteoclastogenesis and osteoblastogenesis in vascular calcification. Front Cardiovasc Med 8:639740. https:\/\/doi.org\/10.3389\/fcvm.2021.639740","journal-title":"Front Cardiovasc Med"},{"key":"7553_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S0100-879X2007000400001","volume":"40","author":"C Danilevicius","year":"2007","unstructured":"Danilevicius C, Lopes J, Pereira RMR (2007) Bone metabolism and vascular calcification. Braz J Med Biol Res 40:435\u2013442","journal-title":"Braz J Med Biol Res"},{"key":"7553_CR30","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938\u20132948","journal-title":"Circulation"},{"key":"7553_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrendo.2012.36","volume":"8","author":"B Thompson","year":"2012","unstructured":"Thompson B, Towler DA (2012) Arterial calcification and bone physiology: role of the bone\u2013vascular axis. Nat Rev Endocrinol 8:529\u2013543","journal-title":"Nat Rev Endocrinol"},{"key":"7553_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jbmr.3089","volume":"32","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Crepaldi G, Solmi M, Cooper C, Harvey NC, Reginster JY, Rizzoli R, Civitelli R, Schofield P (2017) Relationship between low bone mineral density and fractures with incident cardiovascular disease: a systematic review and meta-analysis. J Bone Miner Res 32:1126\u20131135","journal-title":"J Bone Miner Res"},{"key":"7553_CR33","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.annepidem.2007.06.005","volume":"17","author":"ME Mussolino","year":"2007","unstructured":"Mussolino ME, Armenian HK (2007) Low bone mineral density, coronary heart disease, and stroke mortality in men and women: the Third National Health and Nutrition Examination Survey. Ann Epidemiol 17:841\u2013846","journal-title":"Ann Epidemiol"},{"key":"7553_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00198-011-1631-0","volume":"23","author":"P Wiklund","year":"2012","unstructured":"Wiklund P, Nordstr\u00f6m A, Jansson J-H, Weinehall L, Nordstr\u00f6m P (2012) Low bone mineral density is associated with increased risk for myocardial infarction in men and women. Osteoporos Int 23:963\u2013970","journal-title":"Osteoporos Int"},{"key":"7553_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/joim.12369","volume":"277","author":"M Lorentzon","year":"2015","unstructured":"Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277:650\u2013661","journal-title":"J Intern Med"},{"key":"7553_CR36","doi-asserted-by":"publisher","first-page":"e004344","DOI":"10.1161\/JAHA.116.004344","volume":"6","author":"RB Fohtung","year":"2017","unstructured":"Fohtung RB, Brown DL, Koh WJ, Bartz TM, Carbone LD, Civitelli R, Stein PK, Chaves PH, Kestenbaum BR, Kizer JR (2017) Bone mineral density and risk of heart failure in older adults: the cardiovascular health study. J Am Heart Assoc 6:e004344. https:\/\/doi.org\/10.1161\/JAHA.116.004344","journal-title":"J Am Heart Assoc"},{"key":"7553_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/jgs.13405","volume":"63","author":"KL Pedula","year":"2015","unstructured":"Pedula KL, Coleman AL, Yu F, Cauley JA, Ensrud KE, Hochberg MC, Fink HA, Hillier TA (2015) Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures. J Am Geriatr Soc 63:910\u2013917","journal-title":"J Am Geriatr Soc"},{"key":"7553_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/13697137.2016.1200550","volume":"19","author":"SN Lee","year":"2016","unstructured":"Lee SN, Cho JY, Eun YM, Song SW, Moon KW (2016) Associations between osteoporosis and coronary artery disease in postmenopausal women. Climacteric 19:458\u2013462","journal-title":"Climacteric"},{"key":"7553_CR39","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1359\/jbmr.2000.15.10.1974","volume":"15","author":"DM Kado","year":"2000","unstructured":"Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR (2000) Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15:1974\u20131980","journal-title":"J Bone Miner Res"},{"key":"7553_CR40","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00198-022-06317-x","volume":"33","author":"AK Gebre","year":"2022","unstructured":"Gebre AK, Prince RL, Schousboe JT, Kiel DP, Thompson PL, Zhu K, Lim WH, Sim M, Lewis JR (2022) Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density. Osteoporos Int 33:1557\u20131567","journal-title":"Osteoporos Int"},{"key":"7553_CR41","first-page":"77","volume":"13","author":"MY Pang","year":"2013","unstructured":"Pang MY, Zhang M, Li LS, Jones AY (2013) Changes in bone density and geometry of the radius in chronic stroke and related factors: a one-year prospective study. J Musculoskelet Neuronal Interact 13:77\u201388","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"7553_CR42","doi-asserted-by":"publisher","first-page":"e108040","DOI":"10.1371\/journal.pone.0108040","volume":"9","author":"S Piril\u00e4","year":"2014","unstructured":"Piril\u00e4 S, Taskinen M, Turanlahti M, Kajosaari M, M\u00e4kitie O, Saarinen-Pihkala UM, Viljakainen H (2014) Bone health and risk factors of cardiovascular disease-a cross-sectional study in healthy young adults. PLoS ONE 9:e108040. https:\/\/doi.org\/10.1371\/journal.pone.0108040","journal-title":"PLoS ONE"},{"key":"7553_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00223-006-0052-0","volume":"79","author":"GN Farhat","year":"2006","unstructured":"Farhat GN, Strotmeyer ES, Newman AB, Sutton-Tyrrell K, Bauer DC, Harris T, Johnson KC, Taaffe DR, Cauley JA (2006) Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study. Calcif Tissue Int 79:102\u2013111","journal-title":"Calcif Tissue Int"},{"key":"7553_CR44","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00198-007-0338-8","volume":"18","author":"GN Farhat","year":"2007","unstructured":"Farhat GN, Newman AB, Sutton-Tyrrell K, Matthews KA, Boudreau R, Schwartz AV, Harris T, Tylavsky F, Visser M, Cauley JA (2007) The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int 18:999\u20131008","journal-title":"Osteoporos Int"},{"key":"7553_CR45","doi-asserted-by":"publisher","first-page":"1220174","DOI":"10.3389\/fphar.2023.1220174","volume":"14","author":"WH Tsai","year":"2023","unstructured":"Tsai WH, Sung FC, Muo CH, Tsai MC, Wu SI (2023) Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case-control study. Front Pharmacol 14:1220174","journal-title":"Front Pharmacol"},{"key":"7553_CR46","doi-asserted-by":"publisher","first-page":"1362428","DOI":"10.3389\/fendo.2024.1362428","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu P, Liu R, Gyu JM, Cao P, Kang C (2024) Osteoporosis and coronary heart disease: a bi-directional Mendelian randomization study. Front Endocrinol (Lausanne) 15:1362428","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7553_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/gerona\/glac171","volume":"78","author":"AK Gebre","year":"2023","unstructured":"Gebre AK, Lewis JR, Leow K et al (2023) Abdominal aortic calcification, bone mineral density, and fractures: a systematic review and meta-analysis of observational studies. J Gerontol A Biol Sci Med Sci 78:1147\u20131154","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7553_CR48","first-page":"35","volume":"30","author":"AJ Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez AJ, Seeto AH, Tadrous M, Gebre AK, Lewis JR, Fink HA, Ebeling PR (2023) Evidencia de los efectos cardiovasculares de la osteoporosis tratamientos en ensayos aleatorios de posmenop\u00e1usicas mujeres: una revisi\u00f3n sistem\u00e1tica y una red bayesiana metan\u00e1lisis. Revista Sociedad Argentina de Endocrinolog\u00eda Ginecol\u00f3gica y Reproductiva 30:35\u201336","journal-title":"Revista Sociedad Argentina de Endocrinolog\u00eda Ginecol\u00f3gica y Reproductiva"},{"key":"7553_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40264-024-01475-9","volume":"48","author":"S-H Cheng","year":"2025","unstructured":"Cheng S-H, Chu W, Chou W-H, Chu W-C, Kang Y-N (2025) Cardiovascular safety of romosozumab compared to commonly used anti-osteoporosis medications in postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials. Drug Saf 48:7\u201323","journal-title":"Drug Saf"},{"key":"7553_CR50","doi-asserted-by":"publisher","first-page":"152304","DOI":"10.1016\/j.semarthrit.2023.152304","volume":"64","author":"S Liu","year":"2024","unstructured":"Liu S, Tan Y, Huang W, Luo H, Pan B, Wu S (2024) Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: a meta-analysis and systematic review. Semin Arthritis Rheum 64:152304. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152304","journal-title":"Semin Arthritis Rheum"},{"key":"7553_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/ehjcvp\/pvab054","volume":"8","author":"KJ Kim","year":"2022","unstructured":"Kim KJ, Kim MS, Hong N, Bae JH, Kim KJ, Kim NH, Rhee Y, Lee J, Kim SG (2022) Cardiovascular risks associated with calcium supplementation in patients with osteoporosis: a nationwide cohort study. European Heart Journal-Cardiovascular Pharmacotherapy 8:568\u2013577","journal-title":"European Heart Journal-Cardiovascular Pharmacotherapy"},{"key":"7553_CR52","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12891-024-07674-w","volume":"25","author":"D-Q Chen","year":"2024","unstructured":"Chen D-Q, Xu W-B, Xiao K-Y, Que Z-Q, Feng J-Y, Sun N-K, Cai D-X, Rui G (2024) PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis. BMC Musculoskelet Disord 25:548","journal-title":"BMC Musculoskelet Disord"},{"key":"7553_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/jbnb.2024.151001","volume":"15","author":"O Santiago","year":"2024","unstructured":"Santiago O, Ruggieri INC, Paulini MR, Feldman S (2024) Influence of statins and fibrates drugs on bone health and regeneration. Journal of Biomaterials and Nanobiotechnology 15:1\u201324","journal-title":"Journal of Biomaterials and Nanobiotechnology"},{"key":"7553_CR54","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.athoracsur.2021.07.035","volume":"113","author":"SJ Park","year":"2022","unstructured":"Park SJ, Jo AJ, Kim HJ, Cho S, Ko MJ, Yun SC, Park D-W, Kim JB (2022) Real-world outcomes of on-vs off-pump coronary bypass surgery: result from Korean Nationwide Cohort. Ann Thorac Surg 113:1989\u20131998","journal-title":"Ann Thorac Surg"},{"key":"7553_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ekir.2022.10.023","volume":"8","author":"AD Lalayiannis","year":"2023","unstructured":"Lalayiannis AD, Crabtree NJ, Ferro CJ et al (2023) Bone Mineral Density and Vascular Calcification in Children and Young Adults With CKD 4 to 5 or on Dialysis. Kidney Int Rep 8:265\u2013273","journal-title":"Kidney Int Rep"},{"key":"7553_CR56","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11914-023-00810-w","volume":"21","author":"JH Tobias","year":"2023","unstructured":"Tobias JH (2023) Sclerostin and cardiovascular disease. Curr Osteoporos Rep 21:519\u2013526","journal-title":"Curr Osteoporos Rep"},{"key":"7553_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ekir.2020.12.002","volume":"6","author":"S Suzuki","year":"2021","unstructured":"Suzuki S, Suzuki M, Hanafusa N, Tsuchiya K, Nitta K (2021) Denosumab recovers aortic arch calcification during long-term hemodialysis. Kidney Int Rep 6:605\u2013612. https:\/\/doi.org\/10.1016\/j.ekir.2020.12.002","journal-title":"Kidney Int Rep"},{"key":"7553_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10557-017-6721-6","volume":"31","author":"G Ferretti","year":"2017","unstructured":"Ferretti G, Bacchetti T, Simental-Mend\u00eda LE, Reiner \u017d, Banach M, Sahebkar A (2017) Raloxifene lowers plasma lipoprotein (a) concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Cardiovasc Drugs Ther 31:197\u2013208","journal-title":"Cardiovasc Drugs Ther"},{"key":"7553_CR59","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/GME.0000000000000197","volume":"21","author":"M Igase","year":"2014","unstructured":"Igase M, Kohara K, Tabara Y, Ohara M, Takita R, Ochi M, Okada Y, Miki T (2014) Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis. Menopause 21:962\u2013966","journal-title":"Menopause"},{"key":"7553_CR60","doi-asserted-by":"publisher","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691","journal-title":"BMJ"},{"key":"7553_CR61","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1359\/JBMR.050711","volume":"20","author":"LB Tank\u00f3","year":"2005","unstructured":"Tank\u00f3 LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912\u20131920","journal-title":"J Bone Miner Res"},{"key":"7553_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1258\/0004563021902134","volume":"39","author":"JR Burnett","year":"2002","unstructured":"Burnett JR, Vasikaran SD (2002) Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Ann Clin Biochem 39:203\u2013210","journal-title":"Ann Clin Biochem"},{"key":"7553_CR63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.mayocp.2021.07.019","volume":"97","author":"I Rodr\u00edguez-G\u00f3mez","year":"2022","unstructured":"Rodr\u00edguez-G\u00f3mez I, Gray SR, Ho FK et al (2022) Osteoporosis and its association with cardiovascular disease, respiratory disease, and cancer: findings from the UK Biobank prospective cohort study. Mayo Clin Proc 97:110\u2013121","journal-title":"Mayo Clin Proc"},{"key":"7553_CR64","doi-asserted-by":"crossref","unstructured":"Ortega MA, De Leon-Oliva D, Gimeno-Longas MJ, et al. (2024) Vascular calcification: molecular networking, pathological implications and translational opportunities. Biomolecules 14:275","DOI":"10.3390\/biom14030275"},{"key":"7553_CR65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3810\/pgm.2014.03.2740","volume":"126","author":"MF McCarty","year":"2014","unstructured":"McCarty MF, DiNicolantonio JJ (2014) The molecular biology and pathophysiology of vascular calcification. Postgrad Med 126:54\u201364","journal-title":"Postgrad Med"},{"key":"7553_CR66","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/GME.0000000000000328","volume":"22","author":"ML Fern\u00e1ndez-Murga","year":"2015","unstructured":"Fern\u00e1ndez-Murga ML, Vinu\u00e9 \u00c1, Caeiro JR, Guede D, Tar\u00edn JJ, Andr\u00e9s V, Cano A (2015) Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model. Menopause 22:428\u2013436","journal-title":"Menopause"},{"key":"7553_CR67","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/1871530320666200604160614","volume":"20","author":"NV Mohamad","year":"2020","unstructured":"Mohamad NV, Ima-Nirwana S, Chin KY (2020) Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency? A review of current evidence. Endocr Metab Immune Disord Drug Targets 20:1478\u20131487","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"7553_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/2047487319834399","volume":"27","author":"M Kanazawa","year":"2020","unstructured":"Kanazawa M, Matsumoto Y, Takahashi K, Suzuki H, Uzuka H, Nishimiya K, Shimokawa H (2020) Treadmill exercise prevents reduction of bone mineral density after myocardial infarction in apolipoprotein E-deficient mice. Eur J Prev Cardiol 27:28\u201335","journal-title":"Eur J Prev Cardiol"},{"key":"7553_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.arteri.2019.03.008","volume":"32","author":"MC Garc\u00eda-G\u00f3mez","year":"2020","unstructured":"Garc\u00eda-G\u00f3mez MC, Vilahur G (2020) Osteoporosis and vascular calcification: a shared scenario. Clin Investig Arterioscler 32:33\u201342. https:\/\/doi.org\/10.1016\/j.arteri.2019.03.008","journal-title":"Clin Investig Arterioscler"},{"key":"7553_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00108-014-3468-z","volume":"55","author":"F Jakob","year":"2014","unstructured":"Jakob F, Seefried L, Schwab M (2014) Age and osteoporosis. Effects of aging on osteoporosis, the diagnostics and therapy. Internist (Berl) 55:755\u2013761","journal-title":"Internist (Berl)"},{"key":"7553_CR71","doi-asserted-by":"crossref","unstructured":"Cheng CH, Chen LR, Chen KH (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23:1376","DOI":"10.3390\/ijms23031376"},{"key":"7553_CR72","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00198-022-06308-y","volume":"33","author":"DB Kimmel","year":"2022","unstructured":"Kimmel DB, Vennin S, Desyatova A, Turner JA, Akhter MP, Lappe JM, Recker RR (2022) Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture. Osteoporos Int 33:1125\u20131136","journal-title":"Osteoporos Int"},{"key":"7553_CR73","doi-asserted-by":"crossref","unstructured":"Poznyak AV, Sadykhov NK, Kartuesov AG, Borisov EE, Sukhorukov VN, Orekhov AN (2022) Aging of vascular system is a complex process: the cornerstone mechanisms. Int J Mol Sci 23:6926","DOI":"10.3390\/ijms23136926"},{"key":"7553_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","volume":"18","author":"DJ Tyrrell","year":"2021","unstructured":"Tyrrell DJ, Goldstein DR (2021) Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol 18:58\u201368","journal-title":"Nat Rev Cardiol"},{"key":"7553_CR75","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.2174\/0929867328666210921161711","volume":"29","author":"IK Koutsaliaris","year":"2022","unstructured":"Koutsaliaris IK, Moschonas IC, Pechlivani LM, Tsouka AN, Tselepis AD (2022) Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke. Curr Med Chem 29:5496\u20135509","journal-title":"Curr Med Chem"},{"key":"7553_CR76","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/ijms23031639","volume":"23","author":"P Anagnostis","year":"2022","unstructured":"Anagnostis P, Florentin M, Livadas S, Lambrinoudaki I, Goulis DG (2022) Bone health in patients with dyslipidemias: an underestimated aspect. Int J Mol Sci 23:1639. https:\/\/doi.org\/10.3390\/ijms23031639","journal-title":"Int J Mol Sci"},{"key":"7553_CR77","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.berh.2022.101758","volume":"36","author":"SL Wilson-Barnes","year":"2022","unstructured":"Wilson-Barnes SL, Lanham-New SA, Lambert H (2022) Modifiable risk factors for bone health & fragility fractures. Best Pract Res Clin Rheumatol 36:101758","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7553_CR78","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00198-024-07126-0","volume":"35","author":"Y Chen","year":"2024","unstructured":"Chen Y, Miao Y, Zhang Q (2024) Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes. Osteoporos Int 35:1441\u20131449","journal-title":"Osteoporos Int"},{"key":"7553_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101793","volume":"36","author":"M Urquiaga","year":"2022","unstructured":"Urquiaga M, Saag KG (2022) Risk for osteoporosis and fracture with glucocorticoids. Best Pract Res Clin Rheumatol 36:101793","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7553_CR80","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3803\/EnM.2020.659","volume":"35","author":"JW Koh","year":"2020","unstructured":"Koh JW, Kim J, Cho H, Ha YC, Kim TY, Lee YK, Kim HY, Jang S (2020) Effects of systemic glucocorticoid use on fracture risk: a population-based study. Endocrinol Metab (Seoul) 35:562\u2013570","journal-title":"Endocrinol Metab (Seoul)"},{"key":"7553_CR81","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3390\/nu12113270","volume":"12","author":"MS Rybchyn","year":"2020","unstructured":"Rybchyn MS, Abboud M, Puglisi DA, Gordon-Thomson C, Brennan-Speranza TC, Mason RS, Fraser DR (2020) Skeletal muscle and the maintenance of vitamin D status. Nutrients 12:3270. https:\/\/doi.org\/10.3390\/nu12113270","journal-title":"Nutrients"},{"key":"7553_CR82","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1556\/OH.2011.29186","volume":"152","author":"A Szab\u00f3","year":"2011","unstructured":"Szab\u00f3 A (2011) Skeletal and extra-skeletal consequences of vitamin D deficiency. Orv Hetil 152:1312\u20131319","journal-title":"Orv Hetil"},{"key":"7553_CR83","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jcot.2019.07.004","volume":"10","author":"N Charoenngam","year":"2019","unstructured":"Charoenngam N, Shirvani A, Holick MF (2019) Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma 10:1082\u20131093","journal-title":"J Clin Orthop Trauma"},{"key":"7553_CR84","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/nu13030830","volume":"13","author":"L Melguizo-Rodr\u00edguez","year":"2021","unstructured":"Melguizo-Rodr\u00edguez L, Costela-Ruiz VJ, Garc\u00eda-Recio E, De Luna-Bertos E, Ruiz C, Illescas-Montes R (2021) Role of vitamin D in the metabolic syndrome. Nutrients 13:830. https:\/\/doi.org\/10.3390\/nu13030830","journal-title":"Nutrients"},{"key":"7553_CR85","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jacc.2021.11.058","volume":"79","author":"A Mehta","year":"2022","unstructured":"Mehta A, Vasquez N, Ayers CR et al (2022) Independent association of lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk. J Am Coll Cardiol 79:757\u2013768","journal-title":"J Am Coll Cardiol"},{"key":"7553_CR86","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcmg.2020.08.036","volume":"14","author":"HY Jin","year":"2021","unstructured":"Jin HY, Weir-McCall JR, Leipsic JA et al (2021) The relationship between coronary calcification and the natural history of coronary artery disease. JACC Cardiovasc Imaging 14:233\u2013242. https:\/\/doi.org\/10.1016\/j.jcmg.2020.08.036","journal-title":"JACC Cardiovasc Imaging"},{"key":"7553_CR87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2009.07.001","volume":"15","author":"V Persy","year":"2009","unstructured":"Persy V, D\u2019Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15:405\u2013416","journal-title":"Trends Mol Med"},{"key":"7553_CR88","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/ijms21082685","volume":"21","author":"SJ Lee","year":"2020","unstructured":"Lee SJ, Lee IK, Jeon JH (2020) Vascular calcification-new insights into its mechanism. Int J Mol Sci 21:2685. https:\/\/doi.org\/10.3390\/ijms21082685","journal-title":"Int J Mol Sci"},{"key":"7553_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jdb8030019","volume":"8","author":"D Halloran","year":"2020","unstructured":"Halloran D, Durbano HW, Nohe A (2020) Bone morphogenetic protein-2 in development and bone homeostasis. J Dev Biol 8:19. https:\/\/doi.org\/10.3390\/jdb8030019","journal-title":"J Dev Biol"},{"key":"7553_CR90","doi-asserted-by":"publisher","first-page":"18946","DOI":"10.1038\/s41598-021-98177-4","volume":"11","author":"M Dekker","year":"2021","unstructured":"Dekker M, Waissi F, Silvis MJM et al (2021) High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome. Sci Rep 11:18946","journal-title":"Sci Rep"},{"key":"7553_CR91","doi-asserted-by":"crossref","unstructured":"Kuzan A, Chwi\u0142kowska A, Maksymowicz K, Abramczyk U, Gamian A (2024) Relationships between osteopontin, osteoprotegerin, and other extracellular matrix proteins in calcifying arteries. Biomedicines 12:847","DOI":"10.3390\/biomedicines12040847"},{"key":"7553_CR92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/ijem.ijem_418_22","volume":"27","author":"N Raizada","year":"2023","unstructured":"Raizada N, Aslam M, Mishra BK, Chawla D, Madhu SV (2023) Can bone-specific alkaline phosphatase be a marker of vascular calcification in type 2 diabetes mellitus? Indian J Endocrinol Metab 27:127\u2013132","journal-title":"Indian J Endocrinol Metab"},{"key":"7553_CR93","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2174\/0929867325666180716104159","volume":"27","author":"G Bj\u00f8rklund","year":"2020","unstructured":"Bj\u00f8rklund G, Svanberg E, Dadar M, Card DJ, Chirumbolo S, Harrington DJ, Aaseth J (2020) The role of matrix Gla protein (MGP) in vascular calcification. Curr Med Chem 27:1647\u20131660","journal-title":"Curr Med Chem"},{"key":"7553_CR94","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/s12891-021-04643-5","volume":"22","author":"B Kan","year":"2021","unstructured":"Kan B, Zhao Q, Wang L, Xue S, Cai H, Yang S (2021) Association between lipid biomarkers and osteoporosis: a cross-sectional study. BMC Musculoskelet Disord 22:759","journal-title":"BMC Musculoskelet Disord"},{"key":"7553_CR95","doi-asserted-by":"publisher","first-page":"e230305","DOI":"10.1530\/EC-23-0305","volume":"12","author":"N Martini","year":"2023","unstructured":"Martini N, Streckwall L, McCarthy AD (2023) Osteoporosis and vascular calcifications. Endocr. \u00a0Endocr Connect 12:e230305. https:\/\/doi.org\/10.1530\/EC-23-0305","journal-title":"\u00a0Endocr Connect"},{"key":"7553_CR96","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/biof.1598","volume":"46","author":"S Toosi","year":"2020","unstructured":"Toosi S, Behravan J (2020) Osteogenesis and bone remodeling: a focus on growth factors and bioactive peptides. BioFactors 46:326\u2013340","journal-title":"BioFactors"},{"key":"7553_CR97","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10741-021-10153-2","volume":"27","author":"M Dutka","year":"2022","unstructured":"Dutka M, Bobi\u0144ski R, Wojakowski W, Francuz T, Paj\u0105k C, Zimmer K (2022) Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases. Heart Fail Rev 27:1395\u20131411","journal-title":"Heart Fail Rev"},{"key":"7553_CR98","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5551\/jat.25882","volume":"22","author":"CJ Lee","year":"2015","unstructured":"Lee CJ, Wang JH, Chen ML, Yang CF, Chen YC, Hsu BG (2015) Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. J Atheroscler Thromb 22:304\u2013312","journal-title":"J Atheroscler Thromb"},{"key":"7553_CR99","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/07853890.2012.727019","volume":"45","author":"M Montagnana","year":"2013","unstructured":"Montagnana M, Lippi G, Danese E, Guidi GC (2013) The role of osteoprotegerin in cardiovascular disease. Ann Med 45:254\u2013264","journal-title":"Ann Med"},{"key":"7553_CR100","doi-asserted-by":"publisher","first-page":"e919159","DOI":"10.12659\/MSM.919159","volume":"26","author":"J Si","year":"2020","unstructured":"Si J, Wang C, Zhang D, Wang B, Zhou Y (2020) Osteopontin in bone metabolism and bone diseases. Med Sci Monit 26:e919159","journal-title":"Med Sci Monit"},{"key":"7553_CR101","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/biomedicines11123178","volume":"11","author":"NPE Kadoglou","year":"2023","unstructured":"Kadoglou NPE, Khattab E, Velidakis N, Gkougkoudi E (2023) The role of osteopontin in atherosclerosis and its clinical manifestations (atherosclerotic cardiovascular diseases)-a narrative review. Biomedicines 11:3178. https:\/\/doi.org\/10.3390\/biomedicines11123178","journal-title":"Biomedicines"},{"key":"7553_CR102","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/biom11071047","volume":"11","author":"K Shirakawa","year":"2021","unstructured":"Shirakawa K, Sano M (2021) Osteopontin in cardiovascular diseases. Biomolecules 11:1047. https:\/\/doi.org\/10.3390\/biom11071047","journal-title":"Osteopontin in cardiovascular diseases. Biomolecules"},{"key":"7553_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.936677","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi X, Wu H, Liu Y, Huang H, Liu L, Yang Y, Jiang T, Zhou M, Dai M (2022) Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: a novel mechanism for paeonol in atherosclerosis treatment. Front Pharmacol 13:936677","journal-title":"Front Pharmacol"},{"key":"7553_CR104","doi-asserted-by":"publisher","first-page":"165912","DOI":"10.1016\/j.bbadis.2020.165912","volume":"1866","author":"W Yu","year":"2020","unstructured":"Yu W, Xiao L, Que Y, Li S, Chen L, Hu P, Xiong R, Seta F, Chen H, Tong X (2020) Smooth muscle NADPH oxidase 4 promotes angiotensin II-induced aortic aneurysm and atherosclerosis by regulating osteopontin. Biochim Biophys Acta Mol Basis Dis 1866:165912","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7553_CR105","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00223-022-01048-x","volume":"112","author":"K Makris","year":"2023","unstructured":"Makris K, Mousa C, Cavalier E (2023) Alkaline phosphatases: biochemistry, functions, and measurement. Calcif Tissue Int 112:233\u2013242","journal-title":"Calcif Tissue Int"},{"key":"7553_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/14653125.2017.1416571","volume":"45","author":"T Tripathi","year":"2018","unstructured":"Tripathi T, Gupta P, Sharma J, Rai P, Gupta VK, Singh N (2018) Bone-specific alkaline phosphatase\u2013a potential biomarker for skeletal growth assessment. J Orthod 45:4\u201310","journal-title":"J Orthod"},{"key":"7553_CR107","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu14102124","volume":"14","author":"M Haarhaus","year":"2022","unstructured":"Haarhaus M, Cianciolo G, Barbuto S, La Manna G, Gasperoni L, Tripepi G, Plebani M, Fusaro M, Magnusson P (2022) Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients 14:2124","journal-title":"Nutrients"},{"key":"7553_CR108","first-page":"1078","volume":"8","author":"E Waked","year":"2011","unstructured":"Waked E, El Shanawani F, Raafat M, Metwally A, Abdel-Khalek A, Hassan M (2011) Bone specific alkaline phosphatase and cardiovascular morbidity among patients on maintenance hemodialysis. Life Science Journal 8:1078\u20131087","journal-title":"Life Science Journal"},{"key":"7553_CR109","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2217\/bmm-2018-0089","volume":"12","author":"J Yan","year":"2018","unstructured":"Yan J, Li L, Zhang M, Cai H, Ni Z (2018) Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients. Biomark Med 12:1231\u20131239","journal-title":"Biomark Med"},{"key":"7553_CR110","doi-asserted-by":"crossref","unstructured":"Shapiro IM, Landis WJ (2024) Local and systemic regulation of mineralization: role of coupling factors, pyrophosphate, polyphosphates, vitamin D, fetuin, matrix Gla protein, and osteopontin. mechanisms of mineralization of vertebrate skeletal and dental tissues. Springer, pp 403\u2013444","DOI":"10.1007\/978-3-031-34304-9_9"},{"key":"7553_CR111","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1074248419838501","volume":"24","author":"B Tesfamariam","year":"2019","unstructured":"Tesfamariam B (2019) Involvement of vitamin K-dependent proteins in vascular calcification. J Cardiovasc Pharmacol Ther 24:323\u2013333","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"10","key":"7553_CR112","first-page":"26402","volume":"73","author":"S Duang","year":"2022","unstructured":"Duang S, Zhang M, Liu C, Dong Q (2022) Parathyroid hormone-induced vascular smooth muscle cells calcification by endoplasmic reticulum stress. J Physiol Pharmacol 73(10):26402","journal-title":"J Physiol Pharmacol"},{"key":"7553_CR113","doi-asserted-by":"crossref","unstructured":"Muniyappa R, Tella SH (2018) Osteoporosis and cardiovascular disease in the elderly. Conn's Handbook of Models for Human Aging. Elsevier, pp 721\u2013733","DOI":"10.1016\/B978-0-12-811353-0.00053-1"},{"key":"7553_CR114","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","volume":"108","author":"N Carrillo-L\u00f3pez","year":"2021","unstructured":"Carrillo-L\u00f3pez N, Mart\u00ednez-Arias L, Fern\u00e1ndez-Villabrille S, Ruiz-Torres MP, Dusso A, Cannata-And\u00eda JB, Naves-D\u00edaz M, Panizo S, Workgroup ERO (2021) Role of the RANK\/RANKL\/OPG and Wnt\/\u03b2-catenin systems in CKD bone and cardiovascular disorders. Calcif Tissue Int 108:439\u2013451","journal-title":"Calcif Tissue Int"},{"key":"7553_CR115","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A, Li Y-P (2024) Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Research 12:39","journal-title":"Bone Research"},{"key":"7553_CR116","doi-asserted-by":"crossref","unstructured":"Iriana S, Tintut Y, Demer LL (2020) The paradoxical relationship between skeletal and cardiovascular mineralization. Cardiovascular Calcification and Bone Mineralization 319\u2013332","DOI":"10.1007\/978-3-030-46725-8_15"},{"key":"7553_CR117","unstructured":"Shaker JL, Deftos L (2023) Calcium and phosphate homeostasis. Endotext [Internet]"},{"key":"7553_CR118","first-page":"1097","volume":"10","author":"JL Yang","year":"2024","unstructured":"Yang JL, Hodara E, Sriprasert I, Shoupe D, Stanczyk FZ (2024) Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials. Menopause 10:1097","journal-title":"Menopause"},{"key":"7553_CR119","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/ijms23031376","volume":"23","author":"C-H Cheng","year":"2022","unstructured":"Cheng C-H, Chen L-R, Chen K-H (2022) Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. Int J Mol Sci 23:1376","journal-title":"Int J Mol Sci"},{"key":"7553_CR120","doi-asserted-by":"publisher","first-page":"12139","DOI":"10.3390\/ijms252212139","volume":"25","author":"S-H Hsu","year":"2024","unstructured":"Hsu S-H, Chen L-R, Chen K-H (2024) Primary Osteoporosis induced by androgen and estrogen deficiency: the molecular and cellular perspective on pathophysiological mechanisms and treatments. Int J Mol Sci 25:12139","journal-title":"Int J Mol Sci"},{"key":"7553_CR121","doi-asserted-by":"publisher","first-page":"111322","DOI":"10.1016\/j.intimp.2023.111322","volume":"127","author":"C Ma","year":"2024","unstructured":"Ma C, Wang Z, Mo L, Wang X, Zhou G, Yi C, Niu W, Liu Y (2024) Tanshinone I attenuates estrogen-deficiency bone loss via inhibiting RANKL-induced MAPK and NF-\u03baB signaling pathways. Int Immunopharmacol 127:111322. https:\/\/doi.org\/10.1016\/j.intimp.2023.111322","journal-title":"Int Immunopharmacol"},{"key":"7553_CR122","doi-asserted-by":"publisher","first-page":"110954","DOI":"10.1016\/j.intimp.2023.110954","volume":"124","author":"S Qiao","year":"2023","unstructured":"Qiao S, Zhang X, Chen Z, Zhao Y, Tzeng C-M (2023) Alloferon-1 ameliorates estrogen deficiency-induced osteoporosis through dampening the NLRP3\/caspase-1\/IL-1\u03b2\/IL-18 signaling pathway. Int Immunopharmacol 124:110954","journal-title":"Int Immunopharmacol"},{"key":"7553_CR123","doi-asserted-by":"publisher","first-page":"175","DOI":"10.11005\/jbm.2022.29.3.175","volume":"29","author":"C Jeong","year":"2022","unstructured":"Jeong C, Kim J, Lim Y, Ha J, Kim MK, Kwon H-S, Song K-H, Kang MI, Baek K-H (2022) Roles of follicle-stimulating hormone on bone metabolism in late postmenopausal women. J Bone Metab 29:175. https:\/\/doi.org\/10.11005\/jbm.2022.29.3.175","journal-title":"J Bone Metab"},{"key":"7553_CR124","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/antiox12020373","volume":"12","author":"G Marcucci","year":"2023","unstructured":"Marcucci G, Domazetovic V, Nediani C, Ruzzolini J, Favre C, Brandi ML (2023) Oxidative stress and natural antioxidants in osteoporosis: novel preventive and therapeutic approaches. Antioxidants 12:373","journal-title":"Antioxidants"},{"key":"7553_CR125","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/ijms24043772","volume":"24","author":"T Iantomasi","year":"2023","unstructured":"Iantomasi T, Romagnoli C, Palmini G, Donati S, Falsetti I, Miglietta F, Aurilia C, Marini F, Giusti F, Brandi ML (2023) Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci 24:3772","journal-title":"Int J Mol Sci"},{"key":"7553_CR126","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/biomedicines11112897","volume":"11","author":"J Vekic","year":"2023","unstructured":"Vekic J, Stromsnes K, Mazzalai S, Zeljkovic A, Rizzo M, Gambini J (2023) Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk. Biomedicines 11:2897","journal-title":"Biomedicines"},{"key":"7553_CR127","doi-asserted-by":"publisher","first-page":"123","DOI":"10.11005\/jbm.2022.29.2.123","volume":"29","author":"KM Kim","year":"2022","unstructured":"Kim KM, Yoon YE, La Yun B, Suh J-W (2022) Association between bone mineral density and coronary atherosclerotic plaque according to plaque composition: registry for the women health cohort for bone, breast, and coronary artery disease study. Journal of Bone Metabolism 29:123","journal-title":"Journal of Bone Metabolism"},{"key":"7553_CR128","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/biology12070993","volume":"12","author":"E Ortona","year":"2023","unstructured":"Ortona E, Pagano MT, Capossela L, Malorni W (2023) The role of sex differences in bone health and healing. Biology 12:993","journal-title":"Biology"},{"key":"7553_CR129","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11897-022-00555-0","volume":"19","author":"MM Willemars","year":"2022","unstructured":"Willemars MM, Nabben M, Verdonschot JA, Hoes MF (2022) Evaluation of the interaction of sex hormones and cardiovascular function and health. Curr Heart Fail Rep 19:200\u2013212","journal-title":"Curr Heart Fail Rep"},{"key":"7553_CR130","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.3390\/molecules28186652","volume":"28","author":"M Ma","year":"2023","unstructured":"Ma M, Zeng H, Yang P, Xu J, Zhang X, He W (2023) Drug delivery and therapy strategies for osteoporosis intervention. Molecules 28:6652","journal-title":"Molecules"},{"key":"7553_CR131","doi-asserted-by":"publisher","first-page":"938447","DOI":"10.3389\/fphar.2022.938447","volume":"13","author":"J Lu","year":"2022","unstructured":"Lu J, Hu D, Ma C, Shuai B (2022) Advances in our understanding of the mechanism of action of drugs (including traditional Chinese medicines) for the intervention and treatment of osteoporosis. Front Pharmacol 13:938447","journal-title":"Front Pharmacol"},{"key":"7553_CR132","doi-asserted-by":"publisher","first-page":"118681","DOI":"10.1016\/j.lfs.2020.118681","volume":"264","author":"A Oryan","year":"2021","unstructured":"Oryan A, Sahvieh S (2021) Effects of bisphosphonates on osteoporosis: focus on zoledronate. Life Sci 264:118681","journal-title":"Life Sci"},{"key":"7553_CR133","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.jfma.2020.12.014","volume":"120","author":"S-T Wu","year":"2021","unstructured":"Wu S-T, Chen J-F, Tsai C-J (2021) The impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease. J Formos Med Assoc 120:1957\u20131966","journal-title":"J Formos Med Assoc"},{"key":"7553_CR134","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bone.2013.12.017","volume":"61","author":"S Gonnelli","year":"2014","unstructured":"Gonnelli S, Caffarelli C, Tanzilli L, Pondrelli C, Lucani B, Franci B, Nuti R (2014) Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women. Bone 61:27\u201332","journal-title":"Bone"},{"key":"7553_CR135","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/gme.0b013e318194cafd","volume":"16","author":"M Celiloglu","year":"2009","unstructured":"Celiloglu M, Aydin Y, Balci P, Kolamaz T (2009) The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis. Menopause 16:689\u2013693","journal-title":"Menopause"},{"key":"7553_CR136","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1161\/ATVBAHA.119.312371","volume":"39","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Weinstock A (2019) Cardiovascular outcomes of romosozumab and protective role of alendronate: a conundrum or clarification. Arterioscler Thromb Vasc Biol 39:1343\u20131350","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7553_CR137","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/CIA.S138002","volume":"12","author":"C Caffarelli","year":"2017","unstructured":"Caffarelli C, Montagnani A, Nuti R, Gonnelli S (2017) Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies. Clin Inter Aging 12:1819\u20131828. https:\/\/doi.org\/10.2147\/CIA.S138002","journal-title":"Clin Inter Aging"},{"key":"7553_CR138","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/jcm13051462","volume":"13","author":"H Kim","year":"2024","unstructured":"Kim H, Lee EJ, Woo S, Rho S, Jung JY (2024) Effect of denosumab on bone health, vascular calcification, and health-related quality of life in hemodialysis patients with osteoporosis: a prospective observational study. J Clin Med 13:1462","journal-title":"J Clin Med"},{"key":"7553_CR139","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2353\/ajpath.2009.080957","volume":"175","author":"S Helas","year":"2009","unstructured":"Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC (2009) Inhibition of receptor activator of NF-\u03baB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 175:473\u2013478","journal-title":"Am J Pathol"},{"key":"7553_CR140","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","volume":"11","author":"W Liu","year":"2015","unstructured":"Liu W, Zhang X (2015) Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues. Mol Med Rep 11:3212\u20133218","journal-title":"Mol Med Rep"},{"key":"7553_CR141","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","volume":"93","author":"M Wu","year":"2013","unstructured":"Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93:365\u2013373","journal-title":"Calcif Tissue Int"},{"key":"7553_CR142","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ecl.2022.01.004","volume":"51","author":"CB Newman","year":"2022","unstructured":"Newman CB (2022) Safety of statins and nonstatins for treatment of dyslipidemia. Endocrinol Metab Clin 51:655\u2013679","journal-title":"Endocrinol Metab Clin"},{"key":"7553_CR143","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12663-023-01873-z","volume":"22","author":"G Pruthi","year":"2023","unstructured":"Pruthi G, Mahajan R, Gupta A, Patil AN, Paramasivam V, Kaundal S (2023) The effects of statins on bone formation around implants placed in animal bones: a systematic review and meta-analysis. J Maxillofac Oral Surg 22:265\u2013286. https:\/\/doi.org\/10.1007\/s12663-023-01873-z","journal-title":"J Maxillofac Oral Surg"},{"key":"7553_CR144","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00223-016-0126-6","volume":"98","author":"NM Appelman-Dijkstra","year":"2016","unstructured":"Appelman-Dijkstra NM, Papapoulos SE (2016) Sclerostin inhibition in the management of osteoporosis. Calcif Tissue Int 98:370\u2013380","journal-title":"Calcif Tissue Int"},{"key":"7553_CR145","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/ATVBAHA.122.317635","volume":"42","author":"J Golledge","year":"2022","unstructured":"Golledge J, Thanigaimani S (2022) Role of sclerostin in cardiovascular disease. Arterioscler Thromb Vasc Biol 42:e187\u2013e202","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7553_CR146","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1210\/jc.2013-1521","volume":"98","author":"KJ Claes","year":"2013","unstructured":"Claes KJ, Viaene L, Heye S, Meijers B, d\u2019Haese P, Evenepoel P (2013) Sclerostin: another vascular calcification inhibitor? J Clin Endocrinol Metab 98:3221\u20133228","journal-title":"J Clin Endocrinol Metab"},{"key":"7553_CR147","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.3390\/ijms21134779","volume":"21","author":"A Catalano","year":"2020","unstructured":"Catalano A, Bellone F, Morabito N, Corica F (2020) Sclerostin and vascular pathophysiology. Int J Mol Sci 21:4779","journal-title":"Int J Mol Sci"},{"key":"7553_CR148","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jbmr.4467","volume":"37","author":"M Frysz","year":"2020","unstructured":"Frysz M, Gergei I, Scharnagl H, Smith GD, Zheng J, Lawlor DA, Herrmann M, Maerz W, Tobias JH (2020) Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors. J Bone Miner Res 37:273\u2013284","journal-title":"J Bone Miner Res"},{"key":"7553_CR149","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T (2020) Senolytic drugs: from discovery to translation. J Intern Med 288:518\u2013536","journal-title":"J Intern Med"},{"key":"7553_CR150","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424\u20131435","journal-title":"Nat Med"},{"key":"7553_CR151","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1111\/jgs.14969","volume":"65","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD (2017) The clinical potential of senolytic drugs. J Am Geriatr Soc 65:2297\u20132301","journal-title":"J Am Geriatr Soc"},{"key":"7553_CR152","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/s41467-021-25453-2","volume":"12","author":"EJ Novais","year":"2021","unstructured":"Novais EJ, Tran VA, Johnston SN, Darris KR, Roupas AJ, Sessions GA, Shapiro IM, Diekman BO, Risbud MV (2021) Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat Commun 12:5213","journal-title":"Nat Commun"},{"key":"7553_CR153","doi-asserted-by":"crossref","unstructured":"Ratih US, Iswanti FC (2024) Senescence-induced atherosclerosis: the potency of senolytic therapy. Bioscientia Medicina: Journal of Biomedicine and Translational Research 8:4682\u20134696","DOI":"10.37275\/bsm.v8i8.1036"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07553-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07553-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07553-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T17:03:10Z","timestamp":1751302990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07553-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":153,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7553"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07553-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mohammad Hasan Sharafi, Afshin Nazari, Mostafa Cheraghi, Faraz Souri, and Morteza Bakhshesh declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}